AstraZeneca PLC Files 6-K for Q1 2025 Results
Ticker: AZN · Form: 6-K · Filed: Apr 29, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, foreign-issuer, sec-filing
Related Tickers: AZN
TL;DR
AZN dropped Q1 results via 6-K filing.
AI Summary
AstraZeneca PLC filed a Form 6-K on April 29, 2025, reporting its first quarter results. The filing is a report of a foreign issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Why It Matters
This filing provides investors with timely information regarding AstraZeneca's financial performance for the first quarter of 2025, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) for a large, established company, not indicating any unusual or high-risk events.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the report
- 001-11960 (company) — SEC File Number
- 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom (company) — Registrant's business address
- 19930422 (date) — Date of name change from ZENECA GROUP PLC
- April 2025 (date) — Reporting period for the Form 6-K
- 20250429 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign issuer filed by AstraZeneca PLC to provide information to the SEC, specifically for the month of April 2025 and reporting its first quarter results.
When was AstraZeneca PLC previously known by another name?
AstraZeneca PLC was formerly known as ZENECA GROUP PLC, with a date of name change on April 22, 1993.
What is AstraZeneca PLC's primary business classification according to the filing?
AstraZeneca PLC is classified under Standard Industrial Classification code 2834, which is 'Pharmaceutical Preparations'.
What is the filing date and period of report for this document?
The filing date is April 29, 2025, and the conformed period of report is also April 29, 2025.
Does AstraZeneca PLC file its annual reports under Form 20-F or 40-F?
The registrant indicates by check mark that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 29, 2025 regarding ASTRAZENECA PLC (AZN).